Jubilant Cadista Valsartan Tablets Recall: Incorrect Excipient Risk
Jubilant Cadista recalls 320mg Valsartan tablets with incorrect excipient (Crospovidone) that may cause serious health issues. Affected lots: VR417065A, VR417066A (expiring 10/2019).
Recall notice
Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).
Contact the company
What happened, in plain English
Jubilant Cadista is recalling 320mg Valsartan tablets that contain an incorrect excipient (Crospovidone) which could cause serious health problems. This recall affects specific batches produced in India and distributed in the US. The product is prescription-only and must be stopped if you have the affected lot numbers. Read more at govinfonow.com/recall/40510-jubilant-cadista-valsartan-tablets-recall-incorrect-excipient-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/40510-jubilant-cadista-valsartan-tablets-recall-incorrect-excipient-risk · Updated October 7, 2026 · FDA enforcement record: FDA #D-0876-2018
Cite this page
“Jubilant Cadista Valsartan Tablets Recall: Incorrect Excipient Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40510-jubilant-cadista-valsartan-tablets-recall-incorrect-excipient-risk. Based on FDA recall #D-0876-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0876-2018%22&limit=1).
Why it’s dangerous
The tablets contain a larger size grade of excipient (Crospovidone) that was not properly declared. This incorrect ingredient could lead to serious health issues when taken as directed by a doctor.
Who’s affected
Prescription patients who received Valsartan tablets with lot numbers VR417065A or VR417066A (expiring 10/2019) from the manufacturer. People taking blood pressure medication are most at risk.
How to tell if you have this one
Check your Valsartan tablets for the lot numbers VR417065A or VR417066A, which expired on 10/2019. The product is prescription-only and sold under NDC 59746-363-90.
- Brand
Jubilant Cadista- Category
Drug
What to do — step by step
Check Your Product
Look for lot numbers VR417065A or VR417066A on the tablet packaging, which expire on 10/2019.
Where it went and when
Where it was distributed
Distributed in 7 states.
FDA distribution: “IN, MI, MS, NC, NJ, NY and OH” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Indiana, Michigan, Mississippi, New Jersey, New York, North Carolina, Ohio.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class III
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Do I need to stop using these tablets?
Yes, if you have the affected lot numbers, you should stop using them immediately.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0876-2018 (May 25, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0876-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.